Norges Bank’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,430,733
Closed -$348M 476
2025
Q4
$348M Buy
+3,430,733
New +$276M 0.04% 382
2025
Q3
Sell
-910,277
Closed -$48.4M 535
2025
Q2
$48.4M Buy
910,277
+435,158
+92% +$22.1M 0.01% 968
2025
Q1
$20.6M Sell
475,119
-425,842
-47% -$21.6M ﹤0.01% 1197
2024
Q4
$50.6M Buy
900,961
+220,184
+32% +$13.7M 0.01% 954
2024
Q3
$46.4M Sell
680,777
-561,325
-45% -$31.7M 0.01% 999
2024
Q2
$52.5M Sell
1,242,102
-689,571
-36% -$37.9M 0.01% 888
2024
Q1
$133M Buy
1,931,673
+305,445
+19% +$19.3M 0.02% 563
2023
Q4
$120M Buy
1,626,228
+51,960
+3% +$3.41M 0.02% 540
2023
Q3
$107M Buy
1,574,268
+238,078
+18% +$20.2M 0.02% 545
2023
Q2
$125M Buy
1,336,190
+444,971
+50% +$34.7M 0.02% 515
2023
Q1
$60.4M Sell
891,219
-58,837
-6% -$3.78M 0.01% 750
2022
Q4
$47M Buy
950,056
+169,953
+22% +$6.94M 0.01% 832
2022
Q3
$25.3M Sell
780,103
-728,462
-48% -$30M 0.01% 1095
2022
Q2
$59.4M Buy
1,508,565
+353,477
+31% +$18.9M 0.02% 695
2022
Q1
$80.8M Sell
1,155,088
-293,452
-20% -$21.5M 0.02% 663
2021
Q4
$113M Sell
1,448,540
-143,877
-9% -$12.7M 0.02% 563
2021
Q3
$152M Buy
1,592,417
+56,428
+4% +$5.96M 0.03% 490
2021
Q2
$191M Buy
1,535,989
+209,774
+16% +$25M 0.04% 424
2021
Q1
$175M Sell
1,326,215
-195,611
-13% -$26.8M 0.04% 433
2020
Q4
$202M Buy
1,521,826
+24,367
+2% +$2.95M 0.05% 360
2020
Q3
$153M Sell
1,497,459
-15,428
-1% -$1.33M 0.04% 401
2020
Q2
$132M Sell
1,512,887
-97,946
-6% -$7.83M 0.04% 414
2020
Q1
$93.4M Buy
1,610,833
+230,893
+17% +$18.7M 0.03% 452
2019
Q4
$128M Buy
1,379,940
+230,182
+20% +$20.2M 0.04% 453
2019
Q3
$104M Buy
1,149,758
+30,849
+3% +$3.51M 0.03% 492
2019
Q2
$132M Buy
1,118,909
+52,790
+5% +$5.32M 0.04% 414
2019
Q1
$92.3M Hold
1,066,119
0.03% 522
2018
Q4
$67.3M Buy
1,066,119
+28,634
+3% +$1.97M 0.03% 593
2018
Q3
$81.9M Buy
1,037,485
+50,818
+5% +$3.31M 0.03% 580
2018
Q2
$59M Sell
986,667
-111,967
-10% -$6.03M 0.02% 720
2018
Q1
$44.3M Sell
1,098,634
-44,795
-4% -$2.19M 0.02% 866
2017
Q4
$60.1M Sell
1,143,429
-83,915
-7% -$4.48M 0.02% 686
2017
Q3
$57.8M Sell
1,227,344
-374,404
-23% -$15.1M 0.02% 692
2017
Q2
$56.7M Sell
1,601,748
-75,924
-5% -$2.34M 0.02% 666
2017
Q1
$39.6M Sell
1,677,672
-208,550
-11% -$4.13M 0.02% 865
2016
Q4
$25.2M Sell
1,886,222
-162,986
-8% -$2.63M 0.01% 1159
2016
Q3
$36.3M Buy
2,049,208
+887,568
+76% +$15.6M 0.02% 810
2016
Q2
$14.2M Buy
1,161,640
+196,820
+20% +$1.48M 0.01% 1410
2016
Q1
$6.5M Hold
964,820
﹤0.01% 1744
2015
Q4
$8.9M Hold
964,820
﹤0.01% 1661
2015
Q3
$17.4M Buy
964,820
+200,000
+26% +$4.59M 0.01% 1219
2015
Q2
$22.7M Hold
764,820
0.01% 1130
2015
Q1
$16.8M Buy
764,820
+43,204
+6% +$1.1M 0.01% 1303
2014
Q4
$19.8M Buy
721,616
+579,098
+406% +$14.1M 0.01% 1212
2014
Q3
$2.76M Buy
+142,518
New +$2.61M ﹤0.01% 2044

Other funds holding EXAS

Norges Bank's EXAS Position: Q1 2026 in Review

Norges Bank sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,430,733 shares — an estimated $348M sold.

Norges Bank first reported a position in EXAS in Q3 2014 and held it in 45 quarters. The position peaked at $348M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Norges Bank reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 3,430,733 Exact Sciences shares in Q1 2026, an estimated $348M.
  • Norges Bank first reported a position in Exact Sciences in Q3 2014 and held it in 45 quarters.
  • Norges Bank's Exact Sciences position peaked at $348M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.